Litcius/Paper detail

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial

Hongnan Mo, Yongpei Yu, Xiaoying Sun, Hewei Ge, Lanlan Yu, Xiuwen Guan, Jingtong Zhai, Aihua Zhu, Yuhan Wei, Jinjing Wang, Xiaoyan Yan, Haili Qian, Binghe Xu, Fei Ma

2024Nature Medicine33 citationsDOI

Topics & Concepts

MedicineOncologyMetastatic breast cancerInternal medicineChemotherapyBreast cancerRandomized controlled trialCancerCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune ResponseLung Cancer Treatments and Mutations
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial | Litcius